论文部分内容阅读
笔者 1996年 6月～ 1999年 6月应用雷公藤多甙治疗活动性强直性脊柱炎 (AS) ,观察其对患者血清可溶性白细胞介素 2受体 (s IL- 2 R)水平的影响及临床指标的改善。1 对象和方法1.1 病例选择 2 9例活动性强直性脊柱炎均符合 AS的纽约诊断标准 [1 ]及陈常胜等提出的活动期标准
The author from June 1996 to June 1999 application of tripterygium glycosides treatment of active ankylosing spondylitis (AS), to observe its serum levels of soluble interleukin 2 receptor (sIL-2R) and clinical The improvement of the indicator. 1 Subjects and methods 1.1 Case Selection 29 cases of ankylosing spondylitis are in line with AS New York diagnostic criteria [1] and Chen Changsheng and other activities proposed by the standards